Trial intelligence / Profile preview

Buprenorphine for acute abdominal pain in opioid-dependent patients

IRCT2014080117811N5Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
May 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of buprenorphine in Abdominal discomfort and opioid use disorder (OUD), sponsored by Arak University of Medical Sciences. Started May 2013; status: completed.

02

Drugs

buprenorphine
03

Conditions

Abdominal discomfortopioid use disorder (OUD)

Beyond the preview

Go deeper on IRCT2014080117811N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014080117811N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call